DARZALEX FASPRO®DARZALEX®
This site is intended for US healthcare professionals.
DARZALEX FASPRO®DARZALEX®
Get in Touch
DARZALEX FASPRO®DARZALEX®
Expert VideosMOAAdditional RegimensNCCN GuidelinesPractice SupportPatient Support & Resources
Get in Touch
FAQs
Patient Site
MM Portfolio
For APPs & Nurses
For APPs
& Nurses
Check IconNOW
APPROVED

DARZALEX FASPRO® + VRd is approved in transplant-ineligible patients with newly diagnosed multiple myelomaNDMM1

DARZALEX FASPRO® monotherapy is the first and only FDA-approved treatment in high-risk smoldering multiple myeloma1DARZALEX FASPRO® monotherapy is now approved in high-risk smoldering multiple myeloma1

Site Map

Heading underline ImageHeading underline Image
NEXT
Return Home
caret right